@article{article, title  = {{Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both: The TRAPEZE Randomized Clinical Trial}},

 url = {{https://eprints.whiterose.ac.uk/101667/ }},

 year = {{2016}},

 month = {{4}},

 author = {{James ND and Pirrie SJ and Pope AM and Barton D and Andronis L and Goranitis I and Collins S and Daunton A and McLaren D and O’Sullivan J and Parker C et al}},

 doi = {{10.1001/jamaoncol.2015.5570}},

 volume = {{2}},

 journal = {{JAMA Oncology}},

 issue = {{4}},

 pages = {{493-493}},

 note = {{Accessed on 2024/12/21}}}